Preclinical pharmacology, pharmacokinetics, and pharmacodynamics of veligrotug, a full antagonist antibody to the IGF-1 receptor in development for thyroid eye disease.
Saved in:
| Title: | Preclinical pharmacology, pharmacokinetics, and pharmacodynamics of veligrotug, a full antagonist antibody to the IGF-1 receptor in development for thyroid eye disease. |
|---|---|
| Authors: | Kaplan R; Department of Research, Viridian Therapeutics, Inc., Waltham, MA, USA., Zhao Y; Department of Research, Viridian Therapeutics, Inc., Waltham, MA, USA., Tsai J; Department of Research, Viridian Therapeutics, Inc., Waltham, MA, USA., Dickinson B; Department of Research, Viridian Therapeutics, Inc., Waltham, MA, USA., Swanson T; Department of Research, Viridian Therapeutics, Inc., Waltham, MA, USA., Foster K; Department of Research, Viridian Therapeutics, Inc., Waltham, MA, USA., Bedian V; Department of Research, Viridian Therapeutics, Inc., Waltham, MA, USA. |
| Source: | MAbs [MAbs] 2025 Dec; Vol. 17 (1), pp. 2585616. Date of Electronic Publication: 2025 Nov 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1942-0870 |
|---|---|
| DOI: | 10.1080/19420862.2025.2585616 |
